vs
Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and Ralliant Corp (RAL). Click either name above to swap in a different company.
Ralliant Corp is the larger business by last-quarter revenue ($529.1M vs $487.7M, roughly 1.1× CLOVER HEALTH INVESTMENTS, CORP.). Ralliant Corp runs the higher net margin — 7.5% vs -10.1%, a 17.7% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs -0.5%). Ralliant Corp produced more free cash flow last quarter ($126.6M vs $-69.0M).
Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.
CLOV vs RAL — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $487.7M | $529.1M |
| Net Profit | $-49.3M | $39.9M |
| Gross Margin | — | 50.8% |
| Operating Margin | -10.1% | 9.8% |
| Net Margin | -10.1% | 7.5% |
| Revenue YoY | 44.7% | -0.5% |
| Net Profit YoY | -123.2% | -56.1% |
| EPS (diluted) | — | $0.35 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $487.7M | — | ||
| Q3 25 | $496.6M | $529.1M | ||
| Q2 25 | $477.6M | $503.3M | ||
| Q1 25 | $462.3M | — | ||
| Q4 24 | $337.0M | — | ||
| Q3 24 | $331.0M | $531.7M | ||
| Q2 24 | $356.3M | $533.7M | ||
| Q1 24 | $346.9M | — |
| Q4 25 | $-49.3M | — | ||
| Q3 25 | $-24.4M | $39.9M | ||
| Q2 25 | $-10.6M | $47.6M | ||
| Q1 25 | $-1.3M | — | ||
| Q4 24 | $-22.1M | — | ||
| Q3 24 | $-9.2M | $90.9M | ||
| Q2 24 | $7.4M | $64.8M | ||
| Q1 24 | $-19.2M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 50.8% | ||
| Q2 25 | — | 49.3% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 24.5% | 52.6% | ||
| Q2 24 | 30.3% | 51.5% | ||
| Q1 24 | 23.6% | — |
| Q4 25 | -10.1% | — | ||
| Q3 25 | -4.9% | 9.8% | ||
| Q2 25 | -2.2% | 11.7% | ||
| Q1 25 | -0.3% | — | ||
| Q4 24 | -6.4% | — | ||
| Q3 24 | -2.7% | 20.9% | ||
| Q2 24 | 2.0% | 19.7% | ||
| Q1 24 | -6.5% | — |
| Q4 25 | -10.1% | — | ||
| Q3 25 | -4.9% | 7.5% | ||
| Q2 25 | -2.2% | 9.5% | ||
| Q1 25 | -0.3% | — | ||
| Q4 24 | -6.6% | — | ||
| Q3 24 | -2.8% | 17.1% | ||
| Q2 24 | 2.1% | 12.1% | ||
| Q1 24 | -5.5% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | $0.35 | ||
| Q2 25 | — | $0.42 | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $0.81 | ||
| Q2 24 | — | $0.57 | ||
| Q1 24 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $78.3M | $264.2M |
| Total DebtLower is stronger | — | $1.1B |
| Stockholders' EquityBook value | $308.7M | $3.0B |
| Total Assets | $541.0M | $5.3B |
| Debt / EquityLower = less leverage | — | 0.39× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $78.3M | — | ||
| Q3 25 | — | $264.2M | ||
| Q2 25 | — | $198.6M | ||
| Q1 25 | — | — | ||
| Q4 24 | $194.5M | — | ||
| Q3 24 | $288.0M | — | ||
| Q2 24 | $254.8M | — | ||
| Q1 24 | $208.3M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | $1.1B | ||
| Q2 25 | — | $1.1B | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $308.7M | — | ||
| Q3 25 | $340.9M | $3.0B | ||
| Q2 25 | $344.2M | $3.0B | ||
| Q1 25 | $336.1M | — | ||
| Q4 24 | $341.1M | — | ||
| Q3 24 | $342.2M | $4.0B | ||
| Q2 24 | $324.9M | $4.0B | ||
| Q1 24 | $292.5M | — |
| Q4 25 | $541.0M | — | ||
| Q3 25 | $559.7M | $5.3B | ||
| Q2 25 | $575.0M | $5.2B | ||
| Q1 25 | $583.7M | — | ||
| Q4 24 | $580.7M | — | ||
| Q3 24 | $653.0M | — | ||
| Q2 24 | $674.2M | — | ||
| Q1 24 | $671.8M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.39× | ||
| Q2 25 | — | 0.38× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-66.9M | $138.6M |
| Free Cash FlowOCF − Capex | $-69.0M | $126.6M |
| FCF MarginFCF / Revenue | -14.1% | 23.9% |
| Capex IntensityCapex / Revenue | 0.4% | 2.3% |
| Cash ConversionOCF / Net Profit | — | 3.47× |
| TTM Free Cash FlowTrailing 4 quarters | $-69.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-66.9M | — | ||
| Q3 25 | $12.1M | $138.6M | ||
| Q2 25 | $5.4M | — | ||
| Q1 25 | $-16.3M | — | ||
| Q4 24 | $34.8M | — | ||
| Q3 24 | $50.0M | — | ||
| Q2 24 | $44.8M | — | ||
| Q1 24 | $25.9M | — |
| Q4 25 | $-69.0M | — | ||
| Q3 25 | $11.4M | $126.6M | ||
| Q2 25 | $4.8M | — | ||
| Q1 25 | $-16.5M | — | ||
| Q4 24 | $33.3M | — | ||
| Q3 24 | $49.6M | — | ||
| Q2 24 | $44.4M | — | ||
| Q1 24 | $25.5M | — |
| Q4 25 | -14.1% | — | ||
| Q3 25 | 2.3% | 23.9% | ||
| Q2 25 | 1.0% | — | ||
| Q1 25 | -3.6% | — | ||
| Q4 24 | 9.9% | — | ||
| Q3 24 | 15.0% | — | ||
| Q2 24 | 12.5% | — | ||
| Q1 24 | 7.3% | — |
| Q4 25 | 0.4% | — | ||
| Q3 25 | 0.1% | 2.3% | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.5% | — | ||
| Q3 24 | 0.1% | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | 0.1% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 3.47× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 6.04× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CLOV
Segment breakdown not available.
RAL
| Industrial Manufacturing | $111.1M | 21% |
| Defense And Space | $93.6M | 18% |
| Diversified Electronics | $91.0M | 17% |
| Test And Measurement | $76.8M | 15% |
| Communications | $60.7M | 11% |
| Semiconductors | $51.4M | 10% |
| Other Direct End Markets | $44.4M | 8% |
